Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Daniel A. Camardo files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Shao-Lee Lin - $2.91M in CUE purchases and sales in the last 12 months
- Sumita Ray - $317K in CUE purchases and sales in the last 12 months
- Michael Vincent Meluzio - $201K in CUE purchases and sales in the last 12 months
- Pasha Sarraf - $100K in CUE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Daniel A. Camardo?
Daniel A. Camardo is a corporate insider of Cue Biopharma, Inc. (CUE). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Daniel A. Camardo last file a Form 4?
The most recent primary Form 4 on record is dated 10 July 2026, one of 2 filings going back to 2026.
